Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantThe IDEA Platform
The National HIV Curriculum is part of the University of Washington School of Medicine Infectious Diseases Education and Assessment (IDEA) Program.
IDEA content, resources, and services are free and accessible 24/7 to help health care professionals and trainees learn how to diagnose, manage, and prevent infectious diseases. Content is up-to-date and based on current federal treatment guidelines.
Registration benefits:
- Earn free CME/CNE/CE and Certificates of Completion
- Use individualized progress trackers to efficiently work through content
- Access all five IDEA curricula using the same email address and password
- Create free learning groups to assign content and track member progress – a popular feature used by clinics, training programs, and other health care entities
- Join a learning group to view and complete assigned content
Learn more about the IDEA platform at https://idea.medicine.uw.edu.
The National HIV Curriculum is now part of the Infectious Diseases Education & Assessment (IDEA) platform.
Your National HIV Curriculum account will work for all websites on the IDEA platform:
